Discover new business opportunities in Virtual Reality Tele-health with Xenon-VR
TAKE THE EYE-EXAM TO YOU.
A virtual reality and artificial intelligence-driven solution that leverages advancements in eye tracking technology to deliver the next generation eye exam process.
Investment Round closes in:
Days
Hours
Minutes
Seconds
$350,000 Capital raised
$100K
$5M
Softcap in 3 Months
Hardcap
Investors Spec
Customer Problem
Products & Services
Target Market
Business Model
Competitors
What is Xenon-VR?
XVR is a portable medical device that conducts multifaceted eye-screening tests to detect ocular deficiencies in different regions of the eye. Continual use on patients allows for detecting the risk of developing life-threatening eye conditions such as glaucoma and diabetic retinopathy. Virtual reality and artificial intelligence-driven solution that leverages advancements in eye-tracking technology to deliver the next generation eye exam process.
Helping eye-care organizations start the journey of business and technology transformation to fast track their way to success.
Smart Application
XVR uses eye-tracking, AI, and machine learning and will help doctors unlock the value of their structured and unstructured patients’ data, deliver real-time insights, and gain complex patients’ data.
Advanced Analytics

We incorporate advanced data analytics within the XVR system using machine learning, and using virtual reality CMS to collect and to offer patients’ data for doctors.

convenient Platform for doctors

We design and implement a Virtual Reality system that blends physical and digital worlds to provide doctors with audio and visual information conveniently and engagingly. We leverage our large knowledge base to deliver solutions that meets doctors’ needs, business, and budget expectations.

Smart Application

The XVR software is custom designed to report the user’s eye conditions to an eye-care provider who views the results on their computer in real-time.

Remove tabletop equipment.

Cost-beneficial to doctors and able to replace all if not most of the tabletop equipment for doctors and create a remote environment where doctors are able to produces 10x more exams per day.

Multiple Exams at the same time

Xenon-VR is able to conduct more than one exam at the same time, using eye-tracking technology and able to produce more accurate results for doctors to review.

Invest Now
XVR currently in Seed-Round investment round and seeking a great partnership.
XVR’s Doctors
Learn more about our medical team and be a part of something great.
Learn More
If you are still have more questions regarding medical or investment.
Global Target Market and Market Pool
According to Global Market Insights Inc, the market is expected to hit at $192 Billion (USD) by 2025.
FUTURE PROSPECTS IN HEALTHCARE
DATA DRIVEN
A Virtual Reality Platform integrated with an Artificial Intelligence-driven algorithm that helps archives eye exam data in the cloud; XVR is enabling remote viewing and analysis of data for doctors and able to examine their patients remotely.
Data-Driven 
The Xenon-VR is multi-functional equipment and the way machine learning works, it will be a data-driven learning platform. XVR will reshape the eye-care industry as we understand it.
PATIENTs EXPERIENCE WITH TELEMEDICINE
The Xenon-VR for telehealth reliably delivers consistent clinical user eperiences, seamlessly integrates within the Xenon-VR platform, and keeps patients connected with their doctors.

U.s.a. Target Market

GLObal Doctors
$65 Billion
21,069 Optometrists
3,058 Eye-Care Clinics
14,6633 Ophthalmic Medical Practitioners
18,593 Opticians
2,961 Retina Specialists
We are raising $5,000,000
  • EBITDA (Million)
  • Total Revenue (Million)
roadmap
Our Strategy and Project Plan
June 2018 -December 2018
The idea of Xenon-VR was started in June of 2018 and several years of search and foundational of the Xenon-VR was formed. In November 2018, Xenon-VR drafted and designed its patents and configuration of the designs.
kk
February – April 2019
In February, Xenon-VR started drafting the prototype designs and began the software structures. In April 2019, It started Pre-Seed Funds Round. After the software structures were completed, the VR development team started coding and modify Virtual Reality Headset hardware.
May 2019 – June 2019
Xenon-VR Files additional 7+ patents for the hardware and software for the Xenon-VR present and futures stages for advancing the technology.
June 2019 – December 2019
Xenon-VR was able to raise 300K for its first pre-seed round from Friends and Family Investors. In November 2019, Xenon-VR also completed its prototype, and collecting data from target (doctors) markets.
Januany 2020 – March 2020 ($ 5 Million) SEEDS-ROUND-FUNDS
Xenon-VR is currently raising its first SEED-ROUND-FUNDS to complete building Xenon-VR product for Market Ready production. Xenon-CR will be using to build a team of engineerings, developers, business experts, and isolating manufacturers and starts R & D development.
Frequently-asked questions

Our Target Audiences

  • Ophthalmologist
  • Optometrist
  • Private Clinics
  • Hospitals
  • Independent Phsicians
  • Private Eye-Care Centers
  • Specialty Clinics
  • Medical Institutions
If you still have more questions regarding our Target Audiences, please contact us now.
First year of gross profit $27,000,000
Fifth year of gross profit $72,000,000
0
Total Available Market (TAM)
0
Serviceable Available Market (SAM)
0
Serviceable Obtainable Market (SOM)
Xenon-VR device will appeal to a broad set of users starting with medical community, and branching out to corporations, schools, NGOs, and any entity that sees healthy eyes as a benefit.
We know that we need to build the operational team. We have focused our resources and time on the product which we will continue to do. This round of investment will help to move the product and the organization forward.
Xenon-VR seeks $5 million to capitalize stages 1 and 2 of our advancement plans which includes establishing eye exam protocols, market-ready-ready development (VR, AI, UX, hardware development), pilot group testing, ongoing QA, packaging, sales channel development, marketing, advertising, social media, SEO, and product launch.
patents

Yes, Xenon-VR currently has 15 patents pending on the technology range from software to hardware. We have certain patents on validation stage and others are in provision stages. We are also in the process of submitting additional patents.

Xenon-VR will be offering 6 exams on first Market-Ready-Product and In the futures , Xenon-VR will be launching additional exams including hardware modules.
V

Visual Field Test

E

Extraocular Muscle Test

C

Color Blindness

A

Amsler Grid

C

Contrast test

C

Confrontation field test.

P

Phoropter

A

Auto Refractor

O

Optical Coherence Tomography (OCT)

F

Fundus Camera

R

Retinoscope, Tonometer, Keratometer

O

Ophthalmoscope

H

Humphrey Visual Field Analyser.

Yes,  presently 3rd party hardware is limited to Xenon-VR mission and in providing the necessary lighting conditions for the eye-exams. 

 

We are customizing Xenon-VR hardware to build Goldman standard requirement of field of view (FOV) and able to collect more accurate data result with advanced technologies. We will be adding future hardware and because present hardware does not allow that where Xenon-VR can easily swappable component.
We are using an off the shelf product to built the prototype with our own software including modifying eye-tracking and eye-exams downloaded. Currently the hardware we are using consists of off the shelf product components, when we go to market ready the product will have our customized hardware to rectify the present hardware limitations 
Yes and No. One of our competitors as Zeiss need FDA approval. Fove is a product like our but used to different purpose of medical sectors,however they falls under Novelty product and does not require standard FDA approval and they are 510(k) exempt.
Xenon-VR will be under Novelty production and will not require a standard FDA apporval and are 510(K) exempt.

1st Year Projection

$27,000,000‬
3 year projection
$75,000,000
Social MediA
Follow up on our Social Channels
Our Team
P1060285-1024x683
Steve Susanibar
Co-Founder & CTO
Micheele-Defosset
Michelle Defossett
CFO & Treasurer
Dr.-Robert-Gilligan
Dr. Robert Gilligan
Chief Medical Officer & O.D
Jeff Martin
Jeffry Martin
Chief Strategy Office
T.O. Tormey June 2019 For Publication (2)
Terrence O. Tormey
CEO
Dr.Kristine_Erickson
Dr. Kristine Erickson
Medical Advisor,/Medical & Research Committee
Zeshan-A-Khan
Zeshan A. Khan
Founder & Chairman
We Are Collaborate And In Discussion With Only With The Best
Partners